鸡抗小鼠IgG H&L (HRP) (ab6814)
Key features and details
- Chicken Anti-Mouse IgG H&L (HRP)
- Conjugation: HRP
- Host species: Chicken
- Suitable for: Dot blot, ELISA, IHC-P, IHC-Fr, Immunomicroscopy, WB, ICC/IF
Related conjugates and formulations
概述
-
产品名称
鸡抗小鼠IgG H&L (HRP)
参阅全部 IgG 二抗 -
宿主
Chicken -
靶标种属
Mouse -
经测试应用
适用于: Dot blot, ELISA, IHC-P, IHC-Fr, Immunomicroscopy, WB, ICC/IFmore details -
免疫原
mouse IgG whole molecule
-
偶联物
HRP
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C. -
存储溶液
Preservative: 0.01% Gentamicin sulphate
Constituents: 1.45% Sodium chloride, 1% BSA, 0.424% Potassium phosphate -
Concentration information loading... -
纯度
Affinity purified -
纯化说明
This product was prepared from monospecific antiserum by immunoaffinity chromatography using mouse IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities. -
共轭说明
Horseradish Peroxidase (HRP) -
克隆
多克隆 -
研究领域
相关产品
-
Substrate reagent
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
应用
| 应用 | Ab评论 | 说明 |
|---|---|---|
| Dot blot |
Use at an assay dependent concentration.
|
|
| ELISA |
Use at an assay dependent dilution.
|
|
| IHC-P |
Use at an assay dependent concentration.
|
|
| IHC-Fr |
Use at an assay dependent concentration.
|
|
| Immunomicroscopy |
Use at an assay dependent concentration.
|
|
| WB |
Use at an assay dependent dilution.
|
|
| ICC/IF |
1/500 - 1/2500.
|
| 说明 |
|---|
|
Dot blot
Use at an assay dependent concentration. |
|
ELISA
Use at an assay dependent dilution. |
|
IHC-P
Use at an assay dependent concentration. |
|
IHC-Fr
Use at an assay dependent concentration. |
|
Immunomicroscopy
Use at an assay dependent concentration. |
|
WB
Use at an assay dependent dilution. |
|
ICC/IF
1/500 - 1/2500. |
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
数据表及文件
-
SDS download
-
Datasheet download
文献 (6)
ab6814 被引用在 6 文献中.
- Lundberg AP et al. Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapy. Neoplasia 23:811-822 (2021). PubMed: 34246985
- Dandekar P et al. Enhanced uptake and siRNA-mediated knockdown of a biologically relevant gene using cyclodextrin polyrotaxane. J Mater Chem B 3:2590-2598 (2015). PubMed: 32262906
- Okal A et al. Re-engineered p53 activates apoptosis in vivo and causes primary tumor regression in a dominant negative breast cancer xenograft model. Gene Ther : (2014). WB . PubMed: 25077773
- Reaz S et al. A single mutant, A276S of p53, turns the switch to apoptosis. Mol Pharm 10:1350-9 (2013). PubMed: 23402381
- Dixon AS et al. Improved coiled-coil design enhances interaction with Bcr-Abl and induces apoptosis. Mol Pharm 9:187-95 (2012). PubMed: 22136227
- Dixon AS et al. Disruption of bcr-abl coiled coil oligomerization by design. J Biol Chem 286:27751-60 (2011). WB . PubMed: 21659527